| |
| |
|
| Insider
Information: |
Ajer Jeffrey Robert |
| Relationship: |
Director |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
105,620 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,387,740 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
105,620 |
|
|
| Total
Value |
$6,387,740 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -20.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Commercial ... |
2024-03-15 |
71,467 |
|
0 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
Director |
2023-09-18 |
34,153 |
2017-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
172 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2012-10-31 |
4 |
A |
$21.76 |
$5,766 |
D/D |
265 |
10,835 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2013-04-30 |
4 |
A |
$23.20 |
$18,490 |
D/D |
797 |
11,367 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2013-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
8,400 |
15,670 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2013-10-31 |
4 |
A |
$27.91 |
$2,763 |
D/D |
99 |
14,979 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2014-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
10,500 |
25,380 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2014-04-30 |
4 |
A |
$29.70 |
$19,780 |
D/D |
666 |
26,046 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2014-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
11,400 |
31,590 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2014-10-31 |
4 |
A |
$31.26 |
$1,469 |
D/D |
47 |
31,637 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2015-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
10,500 |
42,090 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2015-04-30 |
4 |
A |
$51.26 |
$48,341 |
D/D |
943 |
43,033 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2015-10-30 |
4 |
A |
$57.26 |
$1,489 |
D/D |
26 |
35,631 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
• – – |
2016-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
32,583 |
68,188 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2016-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
16,190 |
63,072 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2016-04-29 |
4 |
A |
$51.26 |
$21,275 |
D/D |
415 |
63,487 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2017-02-24 |
4 |
A |
$95.61 |
$1,139,396 |
D/D |
11,917 |
53,259 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2017-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
12,200 |
55,422 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2017-04-28 |
4 |
A |
$70.30 |
$21,232 |
D/D |
302 |
51,834 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2017-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
22,500 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
12,529 |
59,918 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-02-26 |
4/A |
A |
$0.00 |
$0 |
D/D |
12,615 |
60,004 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
12,840 |
64,521 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2018-04-30 |
4 |
A |
$68.78 |
$21,254 |
D/D |
309 |
53,223 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2018-09-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,750 |
20,500 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,557 |
61,692 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2019-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,370 |
62,976 |
0 |
- |
|
172 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
